IFITM3 and hepatocellular carcinoma: Therefore, the 2.24-fold increased expression of IFITM3 in HCC as compared to cirrhosis, demonstrated in our study, can also be attributed to its antiviral signaling and inflammation which are the hallmarks of tumor progression in cirrhosis and HCC cases having viral etiology.